AssetMark Inc
IART icon

AssetMark Inc’s Integra LifeSciences IART Stock Holding History

AssetMark Inc’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-450
Closed -$13.1K – 2313
2024
Q2 		$13.1K Sell
450
-240
-35% -$7.12K ﹤0.01% 1450
2024
Q1 		$24.5K Hold
690
– – ﹤0.01% 1261
2023
Q4 		$30.1K Hold
690
– – ﹤0.01% 1236
2023
Q3 		$26.4K Hold
690
– – ﹤0.01% 1212
2023
Q2 		$28.4K Sell
690
-11
-2% -$529 ﹤0.01% 1172
2023
Q1 		$40.2K Buy
701
+11
+2% +$620 ﹤0.01% 1081
2022
Q4 		$38.7K Hold
690
– – ﹤0.01% 1097
2022
Q3 		$29K Hold
690
– – ﹤0.01% 1062
2022
Q2 		$37K Sell
690
-150
-18% -$9.01K ﹤0.01% 996
2022
Q1 		$54K Sell
840
-5
-0.6% -$329 ﹤0.01% 901
2021
Q4 		$57K Hold
845
– – ﹤0.01% 885
2021
Q3 		$58K Hold
845
– – ﹤0.01% 760
2021
Q2 		$58K Hold
845
– – ﹤0.01% 732
2021
Q1 		$58K Buy
845
+95
+13% +$6.44K ﹤0.01% 710
2020
Q4 		$49K Hold
750
– – ﹤0.01% 717
2020
Q3 		$35K Hold
750
– – ﹤0.01% 736
2020
Q2 		$35K Sell
750
-125
-14% -$6.14K ﹤0.01% 711
2020
Q1 		$39K Buy
+875
New +$45.9K ﹤0.01% 732
2018
Q1 		– Sell
-20
Closed -$1K – 1672
2017
Q4 		$1K Sell
20
-4,312
-100% -$211K ﹤0.01% 1623
2017
Q3 		$219K Sell
4,332
-9,648
-69% -$496K ﹤0.01% 462
2017
Q2 		$762K Sell
13,980
-50,242
-78% -$2.4M 0.01% 306
2017
Q1 		$2.71M Buy
64,222
+52,226
+435% +$2.23M 0.04% 224
2016
Q4 		$257K Buy
11,996
+10,000
+501% +$406K ﹤0.01% 381
2016
Q3 		$82K Buy
+1,996
New +$83.6K ﹤0.01% 526

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AssetMark Inc's IART Position: Q3 2024 in Review

AssetMark Inc sold out of Integra LifeSciences (IART) in Q3 2024, closing a stake of 450 shares — an estimated $13.1K sold.

AssetMark Inc first reported a position in IART in Q3 2016 and held it in 24 quarters. The position peaked at $2.71M in Q1 2017. 225 funds tracked by Wall St. Rank hold IART as of Q3 2024.

  • AssetMark Inc reported no remaining Integra LifeSciences position as of Q3 2024 after selling out during the quarter.
  • AssetMark Inc sold 450 Integra LifeSciences shares in Q3 2024, an estimated $13.1K.
  • AssetMark Inc first reported a position in Integra LifeSciences in Q3 2016 and held it in 24 quarters.
  • AssetMark Inc's Integra LifeSciences position peaked at $2.71M in Q1 2017.
  • 225 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2024.

Based on AssetMark Inc's 13F filing for Q3 2024, filed 1 Nov 2024.